secwatch / observer
8-K filed November 2, 2023, 7:59 PM ET ticker SEM CIK 0001320414
earnings confidence high sentiment positive materiality 0.70

Select Medical Q3 revenue $1.67B (+6.2%), EPS $0.38 (+75.8%), maintains FY outlook

SELECT MEDICAL HOLDINGS CORP

2023-Q3 EPS reported $1.55 revenue$5,005,202,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SELECT MEDICAL HOLDINGS CORP reported third quarter ended September 30, 2023 results: revenue $1,665.7 million, net income $60.8 million, EPS $0.38.

Period
third quarter ended September 30, 2023
Revenue
$1,665.7 million
Net income
$60.8 million
EPS
$0.38
Result
reported results
Exact text from the filing
For the third quarter ended September 30, 2023, revenue increased 6.2% to $1,665.7 million, compared to $1,567.8 million for the same quarter, prior year. Income from operations increased 42.1% to $130.0 million for the third quarter ended September 30, 2023, compared to $91.5 million for the same quarter, prior year. For the third quarter ended September 30, 2023, income from operations included $0.5 million of other operating income, compared to $8.4 million of other operating income for the same quarter, prior year. The other operating income for the third quarter ended September 30, 2022, was principally related to the recognition of payments received under the Coronavirus Aid, Relief, and Economic Security Act Public Health and Social Services Emergency Fund, also referred to as the Provider Relief Fund. Net income increased 59.5% to $60.8 million for the third quarter ended September 30, 2023, compared to $38.1 million for the same quarter, prior year. Adjusted EBITDA increased 2
View on SEC.gov

Browse all earnings releases →

SELECT MEDICAL HOLDINGS CORP filing history →

Source: SEC EDGAR
accession 0001104659-23-113833
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.